Seeing Light At End Of Pandemic Tunnel, Prestige Consumer Healthcare Raises Earnings Guidance

Prestige Consumer Healthcare prepares to “lap the effects” of COVID-19 disruption on, estimating its fiscal year 2021 sales will reach $935m, ahead of earlier projections, and maintaining long-term organic growth targets of 2%-3%.

More from Archive

More from HBW Insight